Avalo Therapeutics Inc (STU:C6K0)

€ 10.7 -0.35 (-3.17%) Market Cap: 11.40 Mil Enterprise Value: -79.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 30/100

Avalo Therapeutics Inc Annual Shareholders Meeting Transcript
Dec 20, 2023
Avalo Therapeutics Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2023
Avalo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 16, 2023
Avalo Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 13, 2023
Avalo Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 14, 2022
Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation Transcript
Oct 19, 2021
Cerecor Inc Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients - Corporate Call Transcript
Jul 26, 2021
Aytu BioScience Inc Acquires Prescription Product Portfolio from Cerecor Inc - M&A Call Transcript
Oct 14, 2019

Avalo Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 14, 2022 / 01:30PM GMT

Release Date Price: €1192.32 (-4.17%)

Transcript

Garry Neil

Avalo Therapeutics, Inc. - Chairman & CEO

Good morning. I'm Garry Neil, Chief Executive Officer of Avalo Therapeutics. I've been asked by Steven Boyd, Chairman of the Board of Directors of the company, to preside at this annual meeting.

I would like to officially call the meeting to order, and welcome you all to the 2022 Annual Shareholders Meeting of Avalo Therapeutics, Inc. This meeting is being held virtually in an effort to make the meeting as accessible as possible to our stockholders. We appreciate your participation today, and we look forward to future stockholders' meetings where we can all be together in person.

Before proceeding to the business of the meeting, I'd like to introduce you to the members of our Board of Directors who are in attendance today through remote access: Steven Boyd, Board Chairman; June Almenoff; Mitchell Chan; Gilla Kaplan; Keith Maher; and Magnus Persson. In addition to members of our Board, we also have the following representatives of management present today through remote access: Chris Sullivan, Chief Financial Officer. Mr. Sullivan

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.